July 28, 2016: Astra released disappointing second-quarter financials, while refusing to comment on a potential acquisition bid by Novartis. Astra reported a total revenue decrease of 3 percent, primarily caused by a 2 percent drop in product sales driven by patent expirations.
July 28, 2016: Along with its dismal half-year financial reports, Astra announced it was halting six pipeline programs. Astra is being hit hard by patent expirations, particularly Crestor, whose sales dropped by 29 percent in the second quarter and 15 percent in the last six months.
July 28, 2016: A two-year consolidation effort that saw the closure of two facilities, changes made at others and impacted more than 2,000 jobs has paid off for Amgen, Robert Bradway, Amgen’s CEO told investors during a quarterly call on Wednesday.
July 28, 2016: Unilife continues to reduce its workforce as it shifts its business focus on active and new customer programs in its portfolio of wearable injector systems. As part of its new strategy, the company formally tapped John Ryan as the new president and CEO.